News By Tag
* Webster VetSource
* Mast Cell Tumors
* Skin Cancer
* Skin Cancer in dogs
* More Tags...
* More Industries...
News By Location
KINAVET Is Now Available From VetSource
VetSource is pleased to announce that KINAVET-CA1 (masitinib mesylate), a new treatment option to address severe mast cell tumors in dogs, is now available.
Kinavet has been granted conditional approval by the U.S. Food & Drug Administration as safe and effective at delaying tumor progression in canines. This powerful new treatment option was developed by AB Science to help reduce symptoms and increase survival. While Kinavet will not cure the disease, it can help manage the disease and improve the pet’s quality of life.
Kinavet contains mastinib, an anti-cancer drug designed for use with dogs suffering from aggressive mast cell tumors (mastocytoma)
Kinavet is unique because unlike other forms of chemotherapy treatments, it comes in a convenient tablet form that can be given at home. This exciting new product is available to order from VetSource via ScriptRightTM, call-in orders, or participating veterinarian e-commerce sites.
For more information contact VetSource customer service or our Pharmacy.
VetSource services are marketed throughout the United States via its partnership with Webster Veterinary (a Patterson Company).
About VetSource: VetSource, is a North American leader in the home delivery of companion-animal pharmaceutical products and pet nutrition. The company works with veterinarians to enhance the veterinarian-
# # #
VetSource, is a North American leader in the home delivery of companion-animal pharmaceutical products and pet nutrition. The company works with veterinarians to enhance the veterinarian-